glp-1 obesity drugs updates today Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Targeted Peptide Weight Loss

"If the promises or the price sound too good to be true, they probably are." Regulators have received hundreds of reports of adverse events tied to compounded semaglutide and tirzepatide, including overdosing, severe nausea, dehydration and other complications, per the health agency

For comparison, the SURMOUNT-1 trial for tirzepatide showed an average of 20.9% weight loss at the highest dose over 72 weeks

Wegovy is a medication approved for weight loss when combined with a reduced-calorie meal plan and increased physical activity

Seeking GLP-1 treatment is a personal healthcare decision and is not reported to your chain of command

The medication regimen and medication-taking behavior should be reevaluated at regular intervals (every 3-6 months) and adjusted as needed to incorporate specific factors that impact the choice of treatment

They are often used in combination with other hypoglycemic agents like glycosidase inhibitors or insulin for better blood glucose management